| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |